Cargando...
Ferumoxytol administration does not alter infarct volume or the inflammatory response to stroke in mice
Ferumoxytol is an ultrasmall superparamagnetic iron oxide (USPIO) nanoparticle that is FDA approved as an intravenous iron replacement therapy for the treatment of iron deficiency anemia in patients with chronic kidney disease. Ferumoxytol has also been used as a contrast agent for cerebral blood vo...
Gardado en:
| Publicado en: | Neurosci Lett |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268374/ https://ncbi.nlm.nih.gov/pubmed/25449870 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neulet.2014.10.041 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|